Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs)

A new series of N-BPs able to inhibit osteoclastogenesis on RAW 246.7 and PBMC cells is presented. The most active compounds were tested for their ability to inhibit the mevalonate pathway.